Definitive Contract 75F40118C10182
Award Date 9/18/18
Potential Completion Date 8/9/22
Potential Value $500K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a $950,450 cost-plus-fixed-fee contract to CFD Research Corporation on June 12, 2023, to develop a computational fluid dynamics and physiologically-based pharmacokinetic (CFD-PBPK) framework for supporting bioequivalence evaluation of ophthalmic drugs. This contract responds to the FDA's Broad Agency Announcement seeking advanced research and development proposals to further regulatory science and innovation, specifically addressing the modernization of...
- This is a $129,850.00 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Analysis & Design Application CO. LTD. (doing business as Cd-Adapco) for computational fluid dynamics (CFD) software. The contract has an ultimate completion date of September 18, 2021 and does not have a set-aside designation. The contract was awarded on September 12, 2016. As a provider of CFD software, Cd-Adapco is supporting the FDA's work in...
- This is a firm-fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Ansys Inc., a provider of engineering simulation software and services. The contract, valued at $121,691.93, is for the provision of computational fluid dynamics (CFD) modeling software and does not have a set-aside designation. The contract was issued under Ansys' General Services Administration (GSA) Federal Supply Schedule IT-70 contract, a $558 million IDIQ vehicle that enables federal agencies...
- The U.S. Food and Drug Administration (FDA) awarded a $1,155,442.55 Cost Plus Fixed Fee contract to Cubrc, Inc. to conduct research and development on the "Immunogenicity Risk of Peptide Drug Generics and Their Impurities: In Silico and In Vitro Assessment and Validation Methods." The contract, which has a period of performance ending September 27, 2022, was issued under the FDA's Broad Agency Announcement (BAA) solicitation for advanced research and development to support regulatory...
- This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
- The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Definitive Contract to Applied Research Associates, Inc. (ARA) worth $793,400.00 to conduct modifications and improvements to hybrid computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) models for predicting nasal corticosteroid deposition, absorption, and bioavailability. The contract has a completion date of September 19, 2022 and was awarded on September 20, 2019....
- The U.S. Food and Drug Administration (FDA) awarded a $13,992 firm fixed-price purchase order to Comsol, Inc. for multiphysics computational fluid dynamics modeling software. The contract, awarded on August 28, 2025, is set to conclude by September 1, 2026, with performance taking place at the FDA's facility in Rockville, Maryland. This award represents a straightforward commercial off-the-shelf software acquisition with no small business set-aside designation. Comsol, Inc., headquartered in...
- This is a $249,977.16 firm fixed price contract awarded to CFD Research Corporation, doing business as CFD Research, by the Department of the Army Medical Command under the SBIR Program Phase I. The contract is for the research and development of "Anionic Nanoparticle Carriers for Neuron-Targeting of Synthetic and Protein Drugs" and is set aside for small businesses. CFD Research is a small business that specializes in engineering simulations and innovative designs across various...
- This is a $239,951 Firm Fixed Price Definitive Contract awarded by the Naval Strategic Systems Programs to CFD Research Corporation, a small business contractor, under the SBIR Program Phase I. The contract is for research and development services in the area of engineering simulations and innovative designs across multiple industries. This award is part of CFD Research's broader portfolio of federal contract work, including prime and subcontract awards from agencies like the Department of...
- This federal contract award to CFD Research Corporation, a small business, was issued by the National Cancer Institute (NCI) under the Small Business Innovation Research (SBIR) program. The $1,499,854.00 cost-plus-fixed-fee contract is for a Phase II SBIR project titled "SYNVIVO-TUMOR: A PHYSIOLOGICAL 3D MODEL OF THE TUMOR MICROENVIRONMENT" under Topic 328. The contract has a period of performance through September 13, 2019 and does not utilize a small business set-aside. CFD...